Nexteligent Holdings Inc (NXGT)

[BIOCHEMUP]

Also their business description changed:

Nexteligent Holdings, Inc. is designed to acquire and consolidate health and wellness businesses that serve healthcare professionals and institutions with products and services that increase profit and operational efficiency. Despite delays, the Company is actively and diligently pursuing its growth strategy. Nexteligent is considered by management to be in its startup phase and manages a modest burn rate as it continues to develop its M&A platform. Through this period of development, and following the launch of Nexteligent in 2020, the Company has navigated industry disruptions, including the impact of COVID-19 and its impediment to business development. Nexteligent’s commitment to executing on its vision remains steadfast and is buttressed by adaptability and resilience to overcome challenges. In particular, the pandemic affected business development and associated projections for the Company’s revenue cycle management group PRMS. In response, Nexteligent has strategically repositioned PRMS to take advantage of its core competencies that remain strong and are central to the PRMS team, which is also now led by a new director of operations. This strategic repositioning enables PRMS to continue serving a core group of external clients and at the same time positions it as a dedicated in-house resource for future acquisitions in need of medical coding, billing, training, and collections.